Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply

被引：0
作者：
Iris M. Markusse
Willem F. Lems
Tom W.J. Huizinga
Cornelia F. Allaart
机构：
[1] Leiden University Medical Center,Department of Rheumatology
[2] VU Medical Center,Department of Rheumatology
[3] Department of Rheumatology,undefined
来源：
Arthritis Research & Therapy | / 17卷
关键词：
Rheumatoid Arthritis; Prognostic Factor; Rheumatoid Arthritis Patient; Relevant Difference; Early Rheumatoid Arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 26 条
  • [1] Smolen JS(2014)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update Ann Rheum Dis 73 492-509
  • [2] Landewe R(2011)Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice Ann Rheum Dis 70 1407-14
  • [3] Breedveld FC(2010)A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the Best study Ann Rheum Dis 69 1333-7
  • [4] Buch M(2014)Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis Arthritis Res Ther 16 430-9
  • [5] Burmester G(2009)The minimally important difference for the Health Assessment Questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials J Rheumatol 36 254-undefined
  • [6] Dougados M(undefined)undefined undefined undefined undefined-undefined
  • [7] Neovius M(undefined)undefined undefined undefined undefined-undefined
  • [8] Simard JF(undefined)undefined undefined undefined undefined-undefined
  • [9] Klareskog L(undefined)undefined undefined undefined undefined-undefined
  • [10] Askling J(undefined)undefined undefined undefined undefined-undefined
123